• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌和贲门癌的手术及当前治疗方法

Surgery and current management for cancer of the esophagus and cardia.

作者信息

DeMeester T R, Barlow A P

机构信息

Department of Surgery, Creighton University School of Medicine, Omaha, Nebraska.

出版信息

Curr Probl Cancer. 1988 Sep-Oct;12(5):243-328. doi: 10.1016/s0147-0272(88)80002-3.

DOI:10.1016/s0147-0272(88)80002-3
PMID:3067984
Abstract

The current status of carcinoma of the esophagus is reviewed, with specific discussions on current problems. These are difficulties in staging the disease, confusion in the classification, surgery vs. radiation therapy, palliative vs. curative resection, transthoracic vs. transhiatal resection for palliation, and stomach vs. colon as an esophageal substitute after resection. The importance of dysphagia as the presenting complaint is stressed, and the etiologic factors for squamous and adenocarcinoma are reviewed, with a focus on Barrett's esophagus. In management, an emphasis is placed on intraoperative staging, the selection of patients for curative resection, the theory and use of en bloc resection, and the effect of tumor localization on the choice of surgical procedure. A description of the operative technique for cervical lesions, and transthoracic, transhiatal, and en bloc resection of thoracic lesions is given. The palliative benefit of bougienage, intubation, surgical bypass, radiotherapy, laser therapy, and electrical coagulation is summarized. The benefits of intubation are stressed. The recent advent of combination therapy, particularly with regard to chemotherapy and surgery, is discussed. Although such therapy is exciting in isolated patients, the results are not sufficiently predictable to be considered as standard therapy. More work needs to be done to identify those patients most apt to benefit from the variety of therapeutic modalities available.

摘要

本文回顾了食管癌的现状,并对当前存在的问题进行了具体讨论。这些问题包括疾病分期的困难、分类的混淆、手术与放射治疗的选择、姑息性切除与根治性切除、姑息性切除时经胸与经裂孔途径的选择以及切除术后胃与结肠作为食管替代物的选择。强调了吞咽困难作为主要症状的重要性,并回顾了鳞状细胞癌和腺癌的病因,重点是巴雷特食管。在治疗方面,重点关注术中分期、根治性切除患者的选择、整块切除的理论与应用以及肿瘤位置对手术方式选择的影响。介绍了颈部病变的手术技术以及胸部病变的经胸、经裂孔和整块切除方法。总结了探条扩张、插管、手术旁路、放射治疗、激光治疗和电凝的姑息治疗效果。强调了插管的益处。讨论了联合治疗的最新进展,特别是化疗与手术联合治疗。尽管这种治疗方法在个别患者中令人振奋,但其结果的可预测性不足,不能被视为标准治疗方法。需要做更多的工作来确定那些最有可能从现有各种治疗方式中获益的患者。

相似文献

1
Surgery and current management for cancer of the esophagus and cardia.食管癌和贲门癌的手术及当前治疗方法
Curr Probl Cancer. 1988 Sep-Oct;12(5):243-328. doi: 10.1016/s0147-0272(88)80002-3.
2
Selective therapeutic approach to cancer of the lower esophagus and cardia.食管下段和贲门癌的选择性治疗方法。
J Thorac Cardiovasc Surg. 1988 Jan;95(1):42-54.
3
Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria.食管癌和贲门癌的食管胃切除术:采用改进的分期标准,对连续三个八年期间标准切除术后的结果和发现进行比较。
J Thorac Cardiovasc Surg. 1997 May;113(5):836-46; discussion 846-8. doi: 10.1016/S0022-5223(97)70256-3.
4
Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.扩大整块食管胃切除术治疗食管下段及贲门癌的优势
J Thorac Cardiovasc Surg. 1993 Nov;106(5):850-8; discussion 858-9.
5
Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.食管和贲门腺癌外科治疗的当前趋势
J Exp Clin Cancer Res. 1999 Sep;18(3):289-94.
6
Endoscopic mucosal resection for staging and therapy of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.内镜黏膜切除术用于食管、贲门及胃上部三分之一腺癌的分期和治疗。
Recent Results Cancer Res. 2010;182:85-91. doi: 10.1007/978-3-540-70579-6_7.
7
Colon substitution for radical treatment of cardia and lower third esophageal cancer.结肠代食管术治疗贲门癌及食管下段癌根治术
Eur J Cardiothorac Surg. 1993;7(11):601-4; discussion 605. doi: 10.1016/1010-7940(93)90247-9.
8
Overview of the current management of carcinoma of the esophagus and cardia.食管癌和贲门癌当前治疗概述
Can J Surg. 1985 Nov;28(6):493-6.
9
[Palliative treatment of esophageal and cardial carcinoma].
Minerva Chir. 1999 Oct;54(10):647-55.
10
[Laser and afterloading therapy: esophageal cancer].
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990:185-91.

引用本文的文献

1
Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients.转化医学学会关于食管癌患者术后肺部感染防治的专家共识
J Thorac Dis. 2018 Feb;10(2):1050-1057. doi: 10.21037/jtd.2018.01.34.
2
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma.术前联合治疗与基质金属蛋白酶(MMP)抑制剂普林司他治疗食管腺癌患者的II期平行设计研究。
Invest New Drugs. 2006 Mar;24(2):135-40. doi: 10.1007/s10637-006-5934-5.
3
Preoperative radiotherapy for esophageal carcinoma.
食管癌的术前放疗
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD001799. doi: 10.1002/14651858.CD001799.pub2.